Clinical Trial Update: Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating post-transplant cyclophosphamide as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Immune System Diseases
• Lymphoma
• Myelodysplastic Syndromes

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Ivan S Moiseev | Conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia | Phase 2 | Status: COMPLETED